Quantel Medical receives FDA approval for Easyret photocoagulator laser

easyret2

Quantel Medical today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on July 25, 2017 for the innovative new Easyret fully integrated 577nm yellow photocoagulator, which is used to treat certain forms of macular edema and peripheral retinal pathologies.

Quantel Medical launches breakthrough SubCyclo laser procedure for treatment of glaucoma

VITRA 810

Quantel Medical (Quantel), a global ophthalmic medical device company dedicated to developing leading technologies to improve the diagnosis and treatment of ocular diseases, today announced the launch of the SubCyclo™ laser procedure at the World Glaucoma Congress (WGC 2017) meeting being held in Helsinki, Finland, June 28 – July 1. The SybCyclo…

Quantel Medical launches new Easyret photocoagulator laser

EASYRET

Quantel Medical (Quantel), a global ophthalmic medical device company dedicated to developing leading technologies to improve the diagnosis and treatment of ocular diseases, today announced the launch of the innovative new Easyret fully integrated 577nm yellow photocoagulator for macular and peripheral retinal pathologies.

The information collected through this form is recorded and transmitted to the relevant LUMIBIRD MEDICAL departments and enables us to send you any reply to a request via the contact form. The legal basis for the processing is consent. The data collected are kept for 3 years in digital format and are only transmitted to LUMIBIRD MEDICAL’s internal departments as well as to our distributors and subsidiaries. You have a right to access, rectify, contest, limit the processing of and erase data. For more information on the use of your data and your rights resulting from the amended French Data Protection Act and the GDPR, please consult our data protection policy or contact our Data Protection Officer at privacy@lumibird.com.
For more informations on how Quantel Medical uses your data, please see our Terms and conditions.